Clinical Trial Update: Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating afatinib (Gilotrif) in advanced non-small cell lung cancer patients who were pre-treated with erlotinib or gefitinib; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gilotrif (Afatinib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED